Journal of Photochemistry and Photobiology B: Biology
Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications
Introduction
Many researchers in the biological sciences appreciate the extraordinary contrast and specificity provided by fluorescence microscopy. Extrapolating this imaging paradigm to whole-body animal imaging is enticing. However, the physical realities associated with imaging in live tissue make this a continuously elusive objective, as will be evidenced in this review paper. Nevertheless, the information derived from in vivo fluorescence imaging systems can be regarded as an important complement to microscopy studies performed on cell cultures and tissue slices because it provides information about specific biological processes in fully integrated living systems1. Fig. 1 illustrates the salient differences between in vitro, ex vivo and in vivo fluorescence from biological applications relating to brain imaging. Though in essence the underlying technological and biological principles appear to be the same, imaging in each of these regimes imposes unique challenges requiring significantly different approaches to system design.
In this review paper, the basic principles of imaging fluorescence in living tissue is described, together with the practical challenges in designing, implementing, and assessing these systems. Methods available to overcome some challenges using advanced imaging system designs are discussed and an appreciation of the importance and challenges relating to modeling light propagation in tissue is provided. Perhaps most important is to realize that there is an intrinsic limit on the biological information that can be extracted from even the most carefully designed in vivo imaging instrument. Understanding these limitations is critical for researchers in the biological sciences wanting to use custom or commercial in vivo systems in the scope of their research. If, at the onset of research planning, the intrinsic limitations do not interfere with investigational endpoints, a choice must be made among several technological offerings. This paper will help to guide these choices for systems currently available commercially and in research laboratories.
The paper is divided into several sections covering the fundamentals of fluorescence imaging through advanced technology topics. Section 2 discusses the intrinsic limitations of whole-body imaging. These limitations relate to the interaction of light with microscopic tissue components as well as with the specificity and sensitivity of the contrast that can currently be generated in living animals. A description is also provided for the different types of imaging technologies that can be used for in vivo imaging emphasizing which biochemical fluorophore properties can be extracted from each. This is followed by a more detailed description of the various hardware components required in whole-body fluorescence imaging, including state-of-the-art illumination and light detection technology. This section concludes with a description of the various imaging geometries that can be used to perform in vivo small animal imaging. Section 3, consists of an extensive survey of the main commercial systems available on the market. This is presented in parallel with a discussion of salient features of in vivo fluorescence imaging in terms of resolution, sensitivity and quantification. Section 4 reviews recent publications where in vivo fluorescence imaging has been used to study certain biological phenomena. Finally, the paper concludes with a Section 5 reviewing the research done in laboratories to improve the capabilities of in vivo fluorescence imaging.
Section snippets
Intrinsic limitations
In considering the potential use of in vivo fluorescence imaging in biological studies, there are intrinsic limitations researchers should probably consider. In part, these limitations relate to the interaction of light with microscopic components of tissue. Also, consideration must be given to difficulties insuring that biomarkers of interest are associated with a detectable level of optical contrast and that the origin of the latter is specific enough to deliver useful objective information.
Results: survey of commercially available systems
This section is focused on the general applications and performance issues relevant for researchers desiring to acquire or build a whole-body in vivo imaging system. As described earlier in this review, there is a variety of important factors that should be used to guide choices for in vivo imaging. The main categories for these factors are: (1) the targeted biological information, (2) the basic instrumentation and data types to be obtained, and (3) the imaging geometry. Specifically, this
Applications
Whole-animal fluorescence imaging has found widespread use in pre-clinical studies of disease progression and pathology, response to therapy, receptor-targeted applications and probe development. An organ system overview of recent developments and applications of in vivo whole-body fluorescence imaging is presented below.
Discussion
Whole-body in vivo fluorescence imaging is evolving, and may likely never reach a steady state, as the applications and technological opportunities continue to drive this evolution. There is a dynamic community of scientists involved in development of innovative approaches to improve and characterize these modalities beyond what has been achieved thus far, and as discoveries are made, the equipment and applications will advance. This research is pursued with the goal of understanding and
Disclaimer
Authors F. Leblond and B. W. Pogue have been consultants for ART Inc in the past, one of the suppliers of an imaging system reviewed in this paper.
Acknowledgements
This work was supported by the National Institutes of Health (NIH) through Award Number K25CA138578 and Grant Numbers RO1CA109558 and RO1CA120368 from the National Cancer Institute (NCI). The authors would like to extend their gratitude to the companies (ART Advanced Research Technologies, Berthold Technologies, Caliper Life Sciences, CRi, Carestream Health, LI-COR Biosciences, UVP and VisEn Medical) who provided the images shown in Fig. 5, as well as most of the information compiled in Table 1
References (178)
- et al.
Seeing the wood through the trees: a review of techniques for distinguishing green fluorescent protein from endogenous autofluorescence
Anal. Biochem.
(2001) Combined magnetic resonance and fluorescence imaging of the living mouse brain reveals glioma response to chemotherapy
Neuroimage
(2009)Hybrid FMT–CT imaging of amyloid-beta plaques in a murine Alzheimer’s disease model
Neuroimage
(2009)Near-infrared fluorescence imaging with fluorescently labeled albumin: a novel method for non-invasive optical imaging of blood–brain barrier impairment after focal cerebral ischemia in mice
J. Neurosci. Methods.
(2009)- et al.
Intrathecal delivery of fluorescent labeled butyrylcholinesterase to the brains of butyrylcholinesterase knock-out mice: visualization and quantification of enzyme distribution in the brain
Neurotoxicology
(2009) Crossing the blood-brain barrier: a potential application of myristoylated polyarginine for in vivo neuroimaging
Neuroimage
(2005)A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages
Chem. Biol.
(2007)Feasibility, sensitivity, and reliability of laser-induced fluorescence imaging of green fluorescent protein-expressing tumors in vivo
Mol. Ther.
(2003)Two-color lymphatic mapping using Ig-conjugated near infrared optical probes
J. Invest. Dermatol.
(2007)Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo
Bone
(2009)
Targeted optical imaging of cancer cells using lectin-binding BODIPY conjugated avidin
Biochem. Biophys. Res. Commun.
Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry
Nucl. Med. Biol.
In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies
Neoplasia
Whole body and tissue imaging of the butyrylcholinesterase knockout mouse injected with near infrared dye labeled butyrylcholinesterase
Chem. Biol. Interact.
Tuturial on diffuse light transport
J. Biomed. Opt.
Fluorescence spectra provide information on the depth of fluorescent lesions in tissue
Appl. Opt.
Contrast-detail analysis characterizes diffuse optical fluorescence tomography image reconstruction
J. Biomed. Opt.
In vivo fluorescence spectroscopy and imaging for oncological applications
Photochem. Photobiol.
Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging
J. Biomed. Opt.
Image guided diffuse optical fluorescence tomography implemented with Laplacian-type regularization
Opt. Express
All-optical anatomical co-registration for molecular imaging of small animals using dynamic contrast
Nat. Photon.
Quantitative optical spectroscopy for tissue diagnosis
Ann. Rev. Phys. Chem.
Tutorial on diffuse light transport
J. Biomed. Opt.
Fluorescence imaging in vivo: raster scanned point-source imaging provides more accurate quantification than broad beam geometries
Tech. Cancer Res. Treat.
Fiber optic bundle design for quantitative fluorescence measurement from tissue
Appl. Opt.
Accuracy of fluorescent tomography in the presence of heterogeneities: study of the normalized born ratio
IEEE Trans. Med. Imag.
Quantification of the hematoporphyrin derivative by fluorescence measurement using dual-wavelength excitation and dual-wavelength detection
Appl. Opt.
All-optical anatomical co-registration for molecular imaging of small animals using dynamic contrast
Nat. Photon.
Fourier transform profilometry for the automatic measurement of 3-D object shapes
Appl. Opt.
Fluorescence molecular tomography resolves protease activity in vivo
Nat. Med.
Noninvasive measurement of aminolevulinic acid-induced protoporphyrin IX fluorescence allowing detection of murine glioma in vivo
J. Biomed. Opt.
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci
Cancer Res.
In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe
Nat. Biotechnol.
Visualizing localized dynamic changes during epileptic seizure onset in vivo with diffuse optical tomography
Med. Phys.
In vivo imaging of the inflammatory receptor CD40 after cerebral ischemia using a fluorescent antibody
Stroke
In vivo near-infrared fluorescence imaging of matrix metalloproteinase activity after cerebral ischemia
J. Cereb. Blood Flow Metab.
Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo
Circulation
In vivo imaging of proteolytic activity in atherosclerosis
Circulation
Nanoparticle PET–CT imaging of macrophages in inflammatory atherosclerosis
Circulation
Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo
Circulation
Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infarcted myocardium in vivo
Circulation
Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct
Circ. Res.
Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes
Nat. Med.
Visualization of pulmonary inflammation using noninvasive fluorescence molecular imaging
J. Appl. Physiol.
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer
Proc. Natl. Acad. Sci. USA
In vivo mice lung tumor follow-up with fluorescence diffuse optical tomography
J. Biomed. Opt.
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer
PNAS
Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation
J. Clin. Invest.
Tomographic fluorescence imaging of tumor vascular volume in mice
Radiology
Highly sensitive detection of early-stage pancreatic cancer by multimodal near-infrared molecular imaging in living mice
Int. J. Cancer.
Cited by (514)
Nanomaterials in theranostics
2024, Handbook of Nanomaterials, Volume 2: Biomedicine, Environment, Food, and AgricultureDiagnostic and theranostic technologies used in boron neutron capture therapy – A brief review
2024, Inorganic Chemistry CommunicationsConjugated Polymer Nanoparticles for Tumor Theranostics
2023, Biomacromolecules